Delivery Order SPE2DB22D2005-SPE2DB24FJEA0

Award Date 10/13/23
Potential Completion Date 10/16/23
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,910.80, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of July 9, 2024. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,442.50, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract is a Firm Fixed Price Delivery Order with a completion date of June 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,442.50 firm fixed price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of October 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,088.50, is for the delivery of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. It is a firm fixed-price delivery order with an ultimate completion date of April 30, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award is a delivery order valued at $13,426.20 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a completion date of July 8, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,535.87, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has a completion date of February 10, 2025 and is a firm fixed-price delivery order. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,454.00 firm fixed-price delivery order is for the provision of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of May 9, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,482.00 firm fixed-price delivery order is for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $97,627.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, and has a completion date of March 7, 2025. This contract award is not designated as a set-aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $48,708 Firm Fixed Price Delivery Order contract covers the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of November 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJEA0
    Delivery Order

This federal contract award, valued at $30,212.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of October 16, 2023 and is a firm fixed price agreement. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, with no major subcontractors mentioned. This contract award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/12/25, 9:55 AM